Nurses are planning a one-day strike for September 27 because Dana-Farber is undermining the stability of its nursing workforce in Merrimack Valley and putting patient care quality at risk by not settling a fair contract METHUEN, Mass., Sept. 16, 2023 /PRNewswire/ –The registered nurses of Dana-Farber Cancer Institute – Merrimack Valley, represented by the Massachusetts … Read more
DUBLIN, Sept. 15, 2023 /PRNewswire/ — The “Vacuum Ovens Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global vacuum ovens market exhibited strong growth in 2022, reaching a total valuation of US$ 234.3 million. According to this report the market is poised for continued expansion, … Read more
GENEVA, Sept. 15, 2023 /PRNewswire/ — MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel sirolimus drug-eluting balloon (SELUTION SLR), versus any limus drug-eluting stent (DES). MedAlliance Announces Enrollment … Read more
GOTHENBURG, Sweden, Sept. 14, 2023 /PRNewswire/ — Bronwyn Brophy O´Connor, CEO Vitrolife AB, has acquired 19,350 shares worth 2,495,957 SEK. The total holdings of shares amount to 19,350. The transaction will be reported to The Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations. “I am delighted to invest in the Vitrolife Group as I … Read more
ALEXANDRIA, Va., Sept. 13, 2023 /PRNewswire/ — The National PACE Association (NPA) has announced this year’s theme for National PACE Month in September: “PACE: Where You Belong.” The theme celebrates the ways that the PACE model of care builds and strengthens connections between enrollees, PACE caregivers and family. National PACE Month celebrates the Program of … Read more
Late-breaking oral presentation on the positive primary outcomes of aderamastat, a first-in-class, oral MMP-12 inhibitor in a Phase 2 Phase 2 proof-of-concept allergic asthma study, supporting potential novel anti-inflammatory mechanism for respiratory diseases. TAIPEI, Sept. 12, 2023 /PRNewswire/ — Foresee Pharmaceuticals (TPEx: 6576), (“Foresee”) announced today that the company presented the positive primary outcomes of … Read more
Des accords d’une valeur de 1,88 milliard de dollars américains ont été signés lors du Forum sur l’investissement agroalimentaire SAMARKAND, Ouzbékistan, 11 septembre 2023 /PRNewswire/ — Un nouvel accord définissant les principales priorités de la coopération internationale en matière de sécurité alimentaire a été annoncé lors de la Conférence internationale sur la sécurité alimentaire (jeudi … Read more
In Phase 1b Study, Patients Treated in First-Line Demonstrated a Confirmed Objective Response Rate of 65% THOUSAND OAKS, Calif., Sept. 10, 2023 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced exciting data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study evaluating LUMAKRAS® (sotorasib) with carboplatin and pemetrexed in adult patients with … Read more
BEIJING, Sept. 9, 2023 /PRNewswire/ — A report from People’s Daily: A ceremony marking the entry of troops into the Chinese People’s Liberation Army (PLA) support base in Djibouti was held at the base’s barracks on August 1, 2017, marking the completion and official operation of the base. Then Chief of General Staff of Djibouti … Read more
DUBLIN, Sept. 7, 2023 /PRNewswire/ — The “Global Pathogen Reduction Systems Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global pathogen reduction systems market is poised for robust growth, with an anticipated compound annual growth rate (CAGR) of 19.80% during the forecast period from 2023 to 2031. This surge is primarily … Read more